![](/img/cover-not-exists.png)
Enzalutamide in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC): Long-term overall survival and safety analyses of the phase 3 PREVAIL study
Armstrong, A., Tombal, B., Saad, F., Parli, T., Phung, D., Beer, T.M.Volume:
18
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)30874-7
Date:
March, 2019
File:
PDF, 89 KB
english, 2019